The Portfolio Armor Substack

The Portfolio Armor Substack

Trade Alert: AI Earnings Keep Confirming The Buildout

Two semiconductor-equipment Top Names trades and one final long-dated QURE structure.

Portfolio Armor's avatar
Portfolio Armor
Aug 13, 2026
∙ Paid
Ghibli tech fusion

Our Trade Performance, Updated

Before we get into today’s trade alert, here’s a look at our trade performance year-to-date.

You can see all of our completed trades in this spreadsheet.

The Evidence Keeps Building

During the momentum correction, we wrote several posts arguing that the selloff in AI infrastructure stocks was obscuring what the companies themselves were saying: demand was still accelerating through increasingly specialized parts of the stack.

The AI Buildout Keeps Accelerating

Portfolio Armor
·
Aug 6
The AI Buildout Keeps Accelerating

The Bottlenecks Are Becoming Earnings

Read full story

This week’s reports have continued to support that thesis. Nebius Group N.V. (NBIS 0.00%↑), on which we have an open trade, reported second-quarter revenue of $582 million, up 454% year over year; annualized run-rate revenue of $3 billion; and four new large AI-cloud contracts averaging more than $1 billion each. Its shares jumped 34% on Wednesday.

The operating evidence shows the buildout expanding. Share-price reactions still depend on the expectations already embedded in each stock, which makes entry price decisive.

Today’s two AI trades approach that evidence differently. The first is a longer-dated trade on a semiconductor-equipment company we traded successfully earlier this year. The second is a short-dated earnings trade on another equipment name. Both stocks appeared in our system’s Top Names on Wednesday night.

One More QURE Trade

Our third trade is a different kind of asymmetric setup. In June, we wrote about the FDA reopening an accelerated-approval path for uniQure N.V. (QURE 0.00%↑) and its AMT-130 gene therapy for Huntington’s disease.

The Biology Won

Portfolio Armor
·
Jun 17
The Biology Won

The FDA Blinks

Read full story

We already have shorter-dated QURE exposure, but our Multibaggers analysts remain excited by the stock’s potential. As a reminder, Multibaggers are a subset of accounts from our Market Watchers X list with documented, 100%+ winners. Today’s final QURE structure has a January 2028 expiration designed to span the catalyst window we expect to matter most: remaining clinical updates, the planned U.S. and U.K. regulatory path, and early European engagement. Then we’ll let our QURE structures work without adding more exposure.

Today’s First Top Names Trade

Semiconductor manufacturing equipment / AI-capex theme

RSI: 53; Chartmill Technical Rating: 8; Setup Rating: 6; Fundamental Rating: 7.

User's avatar

Continue reading this post for free, courtesy of Portfolio Armor.

Or purchase a paid subscription.
© 2026 Portfolio Armor · Market data by Intrinio · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture